Polycystic Ovarian Syndrome Treatment Market Size, Share & Trends | Industry Growth

 


Polycystic ovary syndrome or PCOS is a hormonal disorder that's common among women of childbearing age. PCOS causes infrequent or prolonged menstrual cycle or excess male hormone levels. Presently, there is no cure for PCOS, however, various medications are used to regulate menstrual cycle and to handle apparent symptoms of PCOS.


The Polycystic Ovarian Syndrome (PCOS) Treatment Market is anticipated to develop because of the key driving factors such as rising genetic & hormonal disorders and a growing awareness among the in-patient population. However, growing popularity of combination drugs and their rising adoption among the in-patient population will likely grow industry during the forecast period.


Presently, no specific drug for this condition is commercially available. Thus, treating apparent symptoms of the disorder is the prime aim of the treatment regimen. This syndrome has a wide variety of symptoms as a result of which a range of drug class/combinations are utilized in therapeutics. Therefore, market leaders are aiming to develop a specific drug/treatment to cure the basis cause of this disease. AstraZeneca is one of the leaders associated with developing such a drug.


Comments

Popular posts from this blog

Cross Linked Polyethylene Market Growth Accelerated by Increasing demand from pipe and cables application

Soda Ash Is An Essential Component Of Water Treatment

It Is Incredibly Effective To Create A Cohesive Online And In-Store Experience Using Smart Beacons